BPMC logo

Blueprint Medicines (BPMC) Accounts Payable

Annual Accounts Payable

$6.79 M
+$2.08 M+44.16%

December 31, 2024


Summary


Performance

BPMC Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Quarterly Accounts Payable

$6.79 M
+$2.07 M+43.98%

December 31, 2024


Summary


Performance

BPMC Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBPMCbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

BPMC Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+44.2%+39.8%
3 y3 years-18.5%+39.8%
5 y5 years+41.7%+39.8%

BPMC Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-18.5%+148.8%-62.2%+148.8%
5 y5-year-18.5%+148.8%-62.2%+267.6%
alltimeall time-18.5%+734.1%-62.2%+734.1%

Blueprint Medicines Accounts Payable History

DateAnnualQuarterly
Dec 2024
$6.79 M(+44.2%)
$6.79 M(+44.0%)
Sep 2024
-
$4.72 M(-2.9%)
Jun 2024
-
$4.86 M(-1.4%)
Mar 2024
-
$4.93 M(+4.6%)
Dec 2023
$4.71 M(+72.6%)
$4.71 M(-32.4%)
Sep 2023
-
$6.96 M(-0.2%)
Jun 2023
-
$6.98 M(-33.9%)
Mar 2023
-
$10.56 M(+287.1%)
Dec 2022
$2.73 M(-67.3%)
$2.73 M(-35.5%)
Sep 2022
-
$4.23 M(-71.9%)
Jun 2022
-
$15.05 M(-16.2%)
Mar 2022
-
$17.96 M(+115.5%)
Dec 2021
$8.33 M(+90.7%)
$8.33 M(-12.7%)
Sep 2021
-
$9.55 M(+417.0%)
Jun 2021
-
$1.85 M(-36.1%)
Mar 2021
-
$2.89 M(-33.9%)
Dec 2020
$4.37 M(-8.8%)
$4.37 M(+49.2%)
Sep 2020
-
$2.93 M(-47.6%)
Jun 2020
-
$5.59 M(-34.0%)
Mar 2020
-
$8.47 M(+76.7%)
Dec 2019
$4.79 M
$4.79 M(+117.6%)
DateAnnualQuarterly
Sep 2019
-
$2.20 M(-66.7%)
Jun 2019
-
$6.61 M(+49.5%)
Mar 2019
-
$4.42 M(+34.1%)
Dec 2018
$3.30 M(-11.9%)
$3.30 M(-17.3%)
Sep 2018
-
$3.99 M(+33.8%)
Jun 2018
-
$2.98 M(-9.4%)
Mar 2018
-
$3.29 M(-12.2%)
Dec 2017
$3.74 M(+69.3%)
$3.74 M(+79.0%)
Sep 2017
-
$2.09 M(-18.9%)
Jun 2017
-
$2.58 M(+13.1%)
Mar 2017
-
$2.28 M(+3.2%)
Dec 2016
$2.21 M(-9.9%)
$2.21 M(+19.6%)
Sep 2016
-
$1.85 M(-32.3%)
Jun 2016
-
$2.73 M(-1.6%)
Mar 2016
-
$2.77 M(+13.0%)
Dec 2015
$2.46 M(+201.6%)
$2.46 M(+57.2%)
Sep 2015
-
$1.56 M(-3.0%)
Jun 2015
-
$1.61 M(-31.0%)
Mar 2015
-
$2.33 M(+186.7%)
Dec 2014
$814.00 K(-42.4%)
$814.00 K
Dec 2013
$1.41 M
-

FAQ

  • What is Blueprint Medicines annual accounts payable?
  • What is the all time high annual accounts payable for Blueprint Medicines?
  • What is Blueprint Medicines annual accounts payable year-on-year change?
  • What is Blueprint Medicines quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Blueprint Medicines?
  • What is Blueprint Medicines quarterly accounts payable year-on-year change?

What is Blueprint Medicines annual accounts payable?

The current annual accounts payable of BPMC is $6.79 M

What is the all time high annual accounts payable for Blueprint Medicines?

Blueprint Medicines all-time high annual accounts payable is $8.33 M

What is Blueprint Medicines annual accounts payable year-on-year change?

Over the past year, BPMC annual accounts payable has changed by +$2.08 M (+44.16%)

What is Blueprint Medicines quarterly accounts payable?

The current quarterly accounts payable of BPMC is $6.79 M

What is the all time high quarterly accounts payable for Blueprint Medicines?

Blueprint Medicines all-time high quarterly accounts payable is $17.96 M

What is Blueprint Medicines quarterly accounts payable year-on-year change?

Over the past year, BPMC quarterly accounts payable has changed by +$1.93 M (+39.77%)